Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Vascular Health and Risk Management|April 2, 2009
Update on the use of trandolapril in the management of cardiovascular disordersAriel Diaz, Anique DucharmeAdvances in Cardiology|August 29, 2006
Heart rate slowing versus other pharmacological antianginal strategiesAriel Diaz, Jean-Claude TardifBio-Protocol|March 18, 2021
Preparation of Synaptoneurosomes to Study the Synapse in the Murine Cerebral CortexAriel Diaz, Enrique Torre, Manuel YepesReceptors & Clinical Investigation|August 15, 2017
Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brainPaola Merino, Ariel Diaz, Manuel YepesThe Journal of Biological Chemistry|December 11, 2019
Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapsePaola Merino, Ariel Diaz, Enrique R Torre, et al.Journal of Cell Science|February 3, 2019
Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminalAriel Diaz, Valerie Jeanneret, Paola Merino, et al.The Journal of Biological Chemistry|May 4, 2018
Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brainPaola Merino, Ariel Diaz, Luis Guillermo Manrique, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 13, 2018
Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processesAriel Diaz, Paola Merino, Luis G Manrique, et al.European Heart Journal|March 19, 2005
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery diseaseAriel Diaz, Martial G Bourassa, Marie-Claude Guertin, et al.Patient Education and Counseling|May 7, 2011
Innovative program to increase physical activity following an acute coronary syndrome: randomized controlled trialJulie Houle, Odette Doyon, Nathalie Vadeboncoeur, et al.Pageof 4